Although some natural peptides are conjugated to large carrier proteins (e.g. KLH, BSA), they always show low immune response. When carrier proteins are insufficient or unavailable for immunization, multiple antigenic peptides (MAPs) are a popular alternative. With decades of hands-on experience in peptide synthesis and research, CD Formulation has developed specific skills and expertise that enable it to produce MAP of superior quality. Our MAP synthesis strategy is innovative and overcomes issues such as increased risk of aggregation that have been present in this type of manufacturing in the past.
MAP is a radially branched polymer peptide macromolecule. By adding a branched oligomycin core skeleton, the orientation of the connected epitope peptide is consistent, which exponentially increases the specific binding ability and reaction sensitivity of the peptide in unit space. The method uses the α- and ε-amino groups of lysine to form a skeleton and uses multiple peptide antigens as the outer surface layer of the branched synthetic polypeptide. MAPs with different numbers of side chains can be synthesized according to the number of lysines. Common MAPs include 2-branched peptides, 4-branched peptides, 8-branched peptides, and 16-branched peptides. MAP has a high molar ratio of peptide antigen to core molecule and a high molecular weight (compared to peptides), making it suitable for the production of high titer and high-affinity antibodies without conjugation to carrier proteins.
Fig. 1 Commonly used synthetic designs of multiple antigenic peptides (MAPs). (Joshi VG, et al., 2013)
At CD Formulation, our team of peptide synthesis experts has the expertise and specific skills to design and synthesize high-quality MAPs for a variety of applications based on your needs.
Our scientists are familiar with a variety of synthesis techniques, including solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and chemo-enzymatic peptide synthesis (CEPS), allowing us to select the most appropriate technology to support each individual peptide synthesis project.
Importantly, our peptide synthesis service includes systematic quality testing and verification to ensure that each batch of peptides meets your specific requirements.
The key strategies of our MAP synthesis service include:
The synthesis of MAPs is challenging because the strict spacing between the eight branches can cause the peptides to aggregate on the resin. This can result in low coupling yields and peptide loss. Our team of peptide experts can overcome these problems by preparing them through SPPS using the following two main techniques.
In divergent synthesis, MAPs are generated step by step from the core to the branches. Our team of peptide synthesis experts uses amino acid raw materials with protecting and blocking groups to sequentially synthesize the surfactant peptides of the desired peptide core, and remove the protecting and blocking groups under strong acid conditions to obtain the MAP product. This technology becomes cumbersome when dealing with large molecules, so this strategy is more suitable for the synthesis of smaller and homogeneous multi-antigenic peptides, such as those used for drug delivery
Convergent synthesis is the synthesis of branches or dendrons separately and then assembling them into complete dendrimers through a pair of specific orthogonal hydrophilic and nucleophilic groups. This technology can reduce the formation of by-products, simplify purification, and produce highly branched and diverse peptides.
In addition to peptide synthesis capabilities, CD Formulation combines flexible GMP manufacturing facilities with cutting-edge peptide analytical knowledge to provide a full range of quality control testing services to accelerate the commercialization of your products, including:
Published Data
Technology: In-Solution Chemoselective Thioether Ligation and All-Solid-Phase Synthesis
Journal: Bioconjug Chem.
IF: 4.12
Published: 2010
Results:
The authors evaluated the advantages and limitations of chemical (thioether) ligation and SPPS approaches for the production of MAP dendrimer peptides and used both approaches to design and prepare three different types of MAP constructs shown in the figure below. The product composition of each synthetic trial was analyzed in detail. The results showed that the strong self-association tendency of M2e seriously disadvantaged the binding in solution, so the target MAP with a specified number of M2e copies could not be produced. In contrast, the fully stepwise SPPS approach proved to be very practical, especially when 6-aminohexanoic acid spacer units were inserted at each branch point to provide increased internal flexibility.
Fig. 2 General structures of the different MAPs in this study. (Kowalczyk W, et al., 2010)
CD Formulation's MAP synthesis services are tailored to meet the specific needs of researchers and organizations seeking high-quality peptides for drug discovery, vaccine development, diagnostics, and other scientific endeavors. Please don't hesitate to contact us if you are interested in our services. We look forward to cooperating with you.
References